text
"['\n1. 요약재무정보\n1) 요약 연결재무제표\n주식회사 에이프로젠메디신과 그 종속기업\n(단위 : 원)\n구 \xa0 \xa0 \xa0분\n제 51(당)기\n제 50(전)기\n제 49(전전)기\n1. 요약 재무상태표\n(2021년 12월 31일 현재)\n(2020년 12월 31일 현재)\n(2019년 12월 31일 현재)\n[유동자산]\n484,328,008,669\n434,503,626,705\n347,111,266,788\n\xa0 현금및현금성자산\n62,377,862,586\n96,615,613,661\n71,671,763,996\n\xa0 매출채권및기타유동채권\n295,911,773,785\n176,692,946,588\n133,982,853,905\n\xa0 기타유동금융자산\n97,430,749,491\n140,847,031,595\n103,190,619,830\n\xa0 재고자산\n20,899,396,536\n17,301,767,529\n17,402,790,712\n\xa0 기타유동자산\n4,205,943,153\n1,546,373,388\n1,658,312,286\n\xa0 당기법인세자산\n3,502,283,118\n1,499,893,944\n1,249,926,059\n\xa0 매각예정비유동자산\n-\n-\n17,955,000,000\n[비유동자산]\n339,783,824,939\n399,804,808,843\n300,062,189,686\n\xa0 기타비유동채권\n146,257,943,156\n142,143,080,004\n1,039,194,183\n\xa0 기타비유동금융자산\n70,884,680,890\n105,289,769,913\n86,230,692,191\n\xa0 관계기업 투자주식\n53,107,501,253\n78,283,860,466\n114,939,472,300\n\xa0 유형자산\n39,251,835,256\n40,186,271,362\n40,914,215,102\n\xa0 무형자산\n3,067,190,944\n3,842,233,372\n3,641,803,408\n\xa0 투자부동산\n24,957,328,927\n27,217,446,260\n27,762,519,178\n\xa0 기타비유동자산\n49,021,129\n53,613,749\n25,534,293,324\n\xa0 이연법인세자산\n2,208,323,384\n2,788,533,717\n-\n자 산 총 계\n824,111,833,608\n834,308,435,548\n647,173,456,474\n[유동부채]\n110,758,603,253\n85,094,012,932\n108,663,565,766\n[비유동부채]\n8,990,787,852\n59,174,540,433\n21,073,755,362\n부 채 총 계\n119,749,391,105\n144,268,553,365\n129,737,321,128\n[지배기업의 소유주지분]\n335,950,869,202\n318,978,122,532\n269,530,240,787\n\xa0 자본금\n99,577,615,000\n91,473,126,500\n76,862,818,000\n\xa0 자본잉여금\n369,796,245,565\n339,378,917,903\n262,373,323,686\n\xa0 기타자본구성요소\n9,128,934,693\n9,128,934,693\n8,222,142,729\n\xa0 기타포괄손익누계액\n(37,299,658,860)\n(35,637,222,413)\n(38,793,586,925)\n\xa0 이익잉여금(결손금)\n(105,252,267,196)\n(85,365,634,151)\n(39,134,456,703)\n[비지배지분]\n368,411,573,301\n371,061,759,651\n247,905,894,559\n자 본 총 계\n704,362,442,503\n690,039,882,183\n517,436,135,346\n2. 요약 포괄손익계산서\n(2021.1.1~2021.12.31)\n(2020.1.1~2020.12.31)\n(2019.1.1~2019.12.31)\n매출액\n141,247,001,612\n127,142,624,221\n78,248,840,939\n영업이익(손실)\n(2,672,313,559)\n3,971,180,948\n2,566,986,184\n당기순이익(손실)\n(12,500,351,319)\n(32,668,134,383)\n18,744,542,511\n- 지배기업소유주지분순이익(손실)\n(18,002,111,538)\n(46,489,934,346)\n(10,420,100,881)\n- 비지배지분순이익(손실)\n5,501,760,219\n13,821,799,963\n29,164,643,392\n기본주당순이익(손실)\n(93)\n(274)\n(76)\n희석주당순이익(손실)\n(93)\n(274)\n(76)\n연결에 포함된 회사 수\n8\n7\n7\n2) 요약 별도재무제표\n주식회사 에이프로젠메디신\n(단위 : 원)\n구 \xa0 \xa0 \xa0분\n제 51(당)기\n제 50(전)기\n제 49(전전)기\n1. 요약 재무상태표\n(2021년 12월 31일 현재)\n(2020년 12월 31일 현재)\n(2019년 12월 31일 현재)\n[유동자산]\n163,683,628,832\n160,211,445,512\n132,146,545,699\n\xa0 현금및현금성자산\n24,266,596,895\n31,007,805,768\n41,162,219,173\n\xa0 매출채권및기타유동채권\n125,275,630,784\n120,685,619,879\n40,549,630,580\n\xa0 기타유동금융자산\n571,226,477\n569,957,755\n40,977,773,435\n\xa0 재고자산\n9,157,286,884\n6,837,643,551\n7,828,840,347\n\xa0 기타유동자산\n3,152,952,523\n1,110,418,559\n1,182,656,384\n\xa0 당기법인세자산\n1,259,935,269\n-\n445,425,780\n[비유동자산]\n410,603,947,697\n423,872,435,990\n324,424,185,660\n\xa0 기타비유동채권\n441,904,223\n529,273,082\n459,407,404\n\xa0 기타비유동금융자산\n61,542,067,170\n74,451,680,828\n85,744,680,423\n\xa0 종속기업 투자주식\n204,134,594,354\n200,519,898,582\n80,185,300,822\n\xa0 관계기업 투자주식\n106,572,500,000\n106,572,500,000\n117,786,000,000\n\xa0 유형자산\n19,879,734,216\n21,193,324,758\n21,451,719,908\n\xa0 무형자산\n222,895,397\n162,849,891\n79,058,303\n\xa0 투자부동산\n17,810,252,337\n18,364,544,292\n18,718,018,800\n\xa0 이연법인세자산\n-\n2,078,364,557\n-\n자산총계\n574,287,576,529\n584,083,881,502\n456,570,731,359\n[유동부채]\n222,693,310,505\n208,066,883,654\n162,564,861,647\n[비유동부채]\n1,935,005,653\n51,898,140,868\n15,138,472,885\n부채총계\n224,628,316,158\n259,965,024,522\n177,703,334,532\n\xa0 자본금\n99,577,615,000\n91,473,126,500\n76,862,818,000\n\xa0 자본잉여금\n370,488,049,143\n340,070,291,662\n262,373,323,686\n\xa0 기타자본구성요소\n8,222,142,729\n8,222,142,729\n8,222,142,729\n\xa0 기타포괄손익누계액\n(37,674,849,907)\n(39,021,928,137)\n(38,748,294,093)\n\xa0 이익잉여금(결손금)\n(90,953,696,594)\n(76,624,775,774)\n(29,842,593,495)\n자본총계\n349,659,260,371\n324,118,856,980\n278,867,396,827\n종속기업 투자주식 평가방법\n원가법\n원가법\n원가법\n관계기업 및 공동기업 투자주식 평가방법\n원가법\n원가법\n원가법\n2. 요약 포괄손익계산서\n(2021.1.1~2021.12.31)\n(2020.1.1~2020.12.31)\n(2019.1.1~2019.12.31)\n매출액\n81,081,675,768\n72,536,685,082\n50,345,276,610\n영업이익(손실)\n295,275,849\n6,419,293,909\n3,030,481,249\n당기순이익(손실)\n(12,040,893,501)\n(46,864,368,222)\n(6,708,467,501)\n기본주당순이익(손실)\n(62)\n(276)\n(49)\n희석주당순이익(손실)\n(62)\n(276)\n(49)\n']"
